| Literature DB >> 24204583 |
Jiang Xiao1, Guiju Gao, Yanmei Li, Wen Zhang, Yunfei Tian, Yingxiu Huang, Yinxiu Huang, Wenjing Su, Ning Han, Di Yang, Hongxin Zhao.
Abstract
BACKGROUND: HIV-related opportunistic infections (OIs) and malignancies continued to cause morbidity and mortality in Chinese HIV-infected individuals. The objective for this study is to elucidate the prevalence and spectrums of OIs and malignancies in HIV-infected patients in the Beijing Ditan Hospital.Entities:
Mesh:
Year: 2013 PMID: 24204583 PMCID: PMC3808390 DOI: 10.1371/journal.pone.0075915
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Study flow diagram.
Demographic Characteristics and Prevalence of OIs and Malignancies.
|
|
|
|
|
|---|---|---|---|
| Total patients | 834(100) | 695(82.8) | 139(17.2) |
| Age(yrs) | 39.2±11.4 | 39.1±11.4 | 39.4±11.6 |
|
| |||
| Northeast China | 145(17.4) | 134(16.1) | 11(1.3) |
| Northwest China | 35(4.2) | 32(3.9) | 3(0.3) |
| North China | 389(46.6) | 329(39.4) | 60(7.2) |
| South China | 179(21.5) | 139(16.7) | 40(4.8) |
| Southwest China | 86(10.3) | 61(7.2) | 25(3.1) |
|
| |||
| Homosexuality | 406(48.7) | 375(45.0) | 31(3.7) |
| Heterosexuality | 205(24.6) | 170(20.4) | 35(4.2) |
| Drug addiction | 34(4.1) | 29(3.9) | 5(0.2) |
| Transfusion | 178(21.3) | 113(13.9) | 65(7.4) |
| Vertical transmission | 11(1.3) | 8(1.0) | 3(0.3) |
|
| |||
| CD4≤50 cells/ul | 492(59.0) | 403(48.3) | 89(11.7) |
| 50<CD4≤100 cells/ul | 150(18.0) | 131(15.7) | 19(2.3) |
| 100<CD4≤200 cells/ul | 120(14.4) | 100(12.0) | 20(2.2) |
| CD4>200 cells/ul | 72(8.6) | 61(7.3) | 11(1.3) |
|
| |||
| Tuberculosis | 271 (32.5) | 227 (27.2) | 44 (5.3) |
| Candidiasis | 245 (29.3) | 202 (24.2) | 43 (5.1) |
| PCP | 187 (22.4) | 163 (19.5) | 24 (2.9) |
| CMV infection | 181 (21.7) | 148 (17.7) | 33 (4.0) |
| Other fungal infection | 135 (16.2) | 112 (13.4) | 23 (2.8) |
| MAC | 94 (11.3) | 85 (10.3) | 9 (1.0) |
| Cryptococcosis | 67 (8.0) | 53 (6.3) | 14 (1.7) |
| PML | 37 (4.4) | 30 (3.6) | 7 (0.8) |
| Cerebral Toxoplasmosis | 29 (3.5) | 23 (2.7) | 6 (0.8) |
| Lymphoma | 27 (2.9) | 21 (2.2) | 6 (0.6) |
|
| 12 (1.4) | 12 (1.4) | 0 (0.0) |
| Kaposi's Sarcoma | 7 (0.8) | 6 (0.6) | 1 (0.1) |
| Cervix carcinoma | 3 (0.3) | -- | 3 (0.3) |
PCP:pneumocystis pneumonia; CMV: cytomegalovirus; MAC: Mycobacterium avium complex; PML: progressive multifocal leukoencephalopathy.
Laboratory results in 834 patients with HIV/AIDS.
|
|
|
|
|
|---|---|---|---|
| Neutrophil count (×109/L) | 2.00-8.00 | 4.00±3.11 | 39.2 |
| Neutrophil (%) | 50.00-75.00 | 68.4±17.0 | 54.4 |
| Lymphocyte count (×109/L) | 1.00-5.00 | 0.93±0.94 | 66.0 |
| Haemoglobin (g/L) | 120.0-160.0 | 108.8±22.9 | 66.9 |
| PLT count (×109/L) | 100.0-300.0 | 208.8±101.6 | 28.9 |
| CD4 cell count (cells/ul) | 706-1125 | 76.4±101.1 | 99.8 |
| ALT (U/L) | 0.0-40.0 | 41.6±60.3 | 30.4 |
| AST (U/L) | 0.0-40.0 | 42.5±56.5 | 30.3 |
| T-BIL (umol/L) | 0.0-18.8 | 10.6±20.1 | 6.8 |
| ALB (g/L) | 35.0-53.0 | 33.4±6.9 | 62.1 |
| BUN (mmol/L) | 1.70-8.30 | 4.5±3.2 | 10.2 |
| Cr (umol/L) | 59.00-104.00 | 62.9±28.6 | 54.8 |
| TG (mmol/L) | 0.57-1.71 | 1.6±1.1 | 35.6 |
| TC (mmol/L) | 2.90-5.68 | 3.5±1.1 | 33.4 |
| LDL (mmol/L) | 0.00-3.36 | 2.1±0.8 | 6.8 |
| HDL (mmol/L) | 1.09-1.92 | 0.7±0.4 | 90.3 |
| FPG(mmol/L) | 4.16-6.44 | 5.6±1.9 | 28.3 |
PLT: Platelet; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase ; T-BIL: Total Bilirubin; ALB: Albumin; BUN: Blood urea nitrogen; Cr: Serum creatinine; TG: triglyceride ; TC: Total cholesterol; LDL: Low-density lipoprotein; HDL: high-density lipoprotein; FPG: Fasting plasma glucose.
Figure 2Spectrum of OIs and Malignancies in HIV-infected Patients based on etiologic and empirical diagnosis in the Beijing Ditan Hospital from January 1, 2009 to November 30, 2012.
Note: PCP:pneumocystis pneumonia; CMV: cytomegalovirus; MAC: Mycobacterium avium complex; PML: progressive multifocal leukoencephalopathy.
Figure 3Prevalence of OIs and Malignancies Related to Geographic Regions in the Study Subjects.
1.Tuberculosis; 2.Candidiasis; 3.PCP; 4.CMV infection; 5.Other fungal infection; 6.MAC; 7.Cryptococcosis; 8. PML; 9. Cerebral Toxoplasmosis; 10. Lymphoma; 11.Penicillium Marneffei infection; 12. Kaposi's Sarcoma.
Figure 4The Prevalence of OIs and Malignancies Related to Transmission Routes in the Study Subjects.
1.Tuberculosis; 2.Candidiasis; 3.PCP; 4.CMV infection; 5.Other fungal infection; 6.MAC; 7.Cryptococcosis; 8. PML; 9. Cerebral Toxoplasmosis; 10. Lymphoma; 11.Penicillium Marneffei infection; 12. Kaposi's Sarcoma.
Figure 5The Prevalence of OIs and Malignancies related to CD4 counts in study subjects.
1.Tuberculosis; 2.Candidiasis; 3.PCP; 4.CMV infection; 5.Other fungal infection; 6.MAC; 7.Cryptococcosis; 8. PML; 9. Cerebral Toxoplasmosis; 10. Lymphoma; 11.Penicillium Marneffei infection; 12. Kaposi's Sarcoma.
AIDS-related OIs and Malignancies and In-hospital Deaths in 834 Patients.
|
|
|
|
|
|---|---|---|---|
| Tuberculosis | |||
| Pulmonary tuberculosis | 222 (26.6) | 74.5(1-312) | 4(2.8) |
| Lymphoid tuberculosis | 74 (8.9) | 67.5(1-276) | -- |
| Tuberculous pleuritis | 52 (6.2) | 89.7(3-351) | -- |
| Tuberculous meningitis | 27 (3.2) | 57.4(3-210) | 8(5.6) |
| Candidiasis | 245 (29.3) | 45.3(1-211) | -- |
| PCP | 187 (22.4) | 35.8(1-211) | 47(33.1) |
| CMV infection | |||
| CMV retinitis | 34 (4.2) | 63.5(1-219) | -- |
| CMV cephalitis | 9 (1.1) | 14.2(1-68) | 3(2.1) |
| CMV colitis | 1(0.1) | 5 | 1(0.7) |
| CMV viremia | 137 (16.4) | 43.3(1-230) | -- |
| Other fungal infection | 135 (16.2) | 57.6(1-278) | -- |
| MAC | 94 (11.3) | 77.3(1-278) | -- |
| Cryptococcosis | |||
| Cryptococcal antigenemia | 67(8.0) | 50.0(2-289) | -- |
| Cryptococcal meningitis | 20(2.4) | 49.9(2-218) | 9(6.3) |
| PML | 37 (4.4) | 128.6(18-246) | 2(1.4) |
| Cerebral Toxoplasmosis | 29 (3.5) | 55.1(1-210) | 3(2.1) |
| Lymphoma | |||
| Diffuse large B cell lymphoma | 12 (1.4) | 105.8(3-208) | 3(2.1) |
| Bunkitt’s lymphoma | 6 (0.7) | 126.8(12-212) | 3(2.1) |
| Unclassified lymphoma | 9(1.1) | 91.6(5-178) | 9(6.3) |
|
| 12 (1.4) | 49.1(4-210) | 1(0.7) |
| Kaposi's Sarcoma | 7 (0.8) | 53.6(10-157) | -- |
| Cervix carcinoma | 3 (0.3) | 403(187-611) | 1(0.7) |
1means causes of death in this table was confirmed in 94 patients, while another 48 patients were dead caused by unexplained infections or malignancies and intracranial space-occupying lesion.
PCP:pneumocystis pneumonia; CMV: cytomegalovirus; MAC: Mycobacterium avium complex; PML: progressive multifocal leukoencephalopathy.
Figure 6Distribution of CD4+T Counts and In-hospital deaths in the Study Subjects.